nach oben

Wiener klinische Wochenschrift

Erschienen in:

01.08.2014 | Editorial

Editorial

verfasst von: Otmar Pachinger, MD, FESC, FAHA, FICA

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 15-16/2014

Einloggen, um Zugang zu erhalten

Excerpt

In today’s fast changing global health-care environment, this journal’s aspiration is to contribute in many directions. Within the network of our academic partners we would like to extend the frontiers of cardiovascular research and to make all innovations accessible to more patients around the world. …

Nächster Artikel The 2014 AHA/ACC valve disease guideline: new stages of disease, new treatment options, and a call for earlier intervention

Titel: Editorial
verfasst von: Otmar Pachinger, MD, FESC, FAHA, FICA
Publikationsdatum: 01.08.2014
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 15-16/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-014-0580-y

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 15-16/2014

Nonalcoholic fatty liver disease (NAFLD) proven by transient elastography in patients with coronary heart disease

The effect of growth hormone replacement therapy on the morphological and functional changes in the left ventricle in patients with adult-onset growth hormone deficiency

The 2014 AHA/ACC valve disease guideline: new stages of disease, new treatment options, and a call for earlier intervention

The prevalence and clinical importance of incidentally detected noncoronary cardiovascular findings with coronary multidetector CT angiography

Levosimendan reverses right-heart failure in a 51-year-old patient after heart transplantation

Evaluation of epicardial fat tissue thickness in patients with hyperthyroidism